HIV Diagnosis in Hospitalized Malawian Infants
|ClinicalTrials.gov Identifier: NCT01388452|
Recruitment Status : Completed
First Posted : July 6, 2011
Last Update Posted : May 14, 2013
University of North Carolina, Chapel Hill
John E. Fogarty International Center (FIC)
National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by (Responsible Party):
University of North Carolina, Chapel Hill
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Completed|
|Actual Primary Completion Date :||December 2011|
|Actual Study Completion Date :||December 2012|
1. Joint United Nations Programme on HIV/AIDS (2008) 2008 Report on the Global AIDS Epidemic. Available: http://data.unaids.org/pub/GlobalReport/2008/JC1511_GR08_ExecutiveSummary_en.pdfAccessed 7 September 2009.
2. The United Nations Children's Fund (2008) Children and AIDS: Third Stocktaking Report, 2008. Available: http://www.unicef.org/publications/index_46585.html. Accessed 7 September 2009.
3. Ministry of Health Malawi: HIV Unit (2008) Annual Report HIV Unit 2008.
4. World Health Organization (2007) Guidance on provider-initiated HIV testing and counseling in health facilities. Available: http://whqlibdoc.who.int/publications/2007/9789241595568_eng.pdf. Accessed 26 August 2009.
Rogerson SR, Gladstone M, Callaghan M, Erhart L, Rogerson SJ, Borgstein E, Broadhead RL. HIV infection among paediatric in-patients in Blantyre, Malawi. Trans R Soc Trop Med Hyg. 2004 Sep;98(9):544-52.
6. Ministry of Health Malawi: HIV Unit (2008) Guidelines for Paediatric HIV Testing and Counseling.
Violari A, Cotton MF, Gibb DM, Babiker AG, Steyn J, Madhi SA, Jean-Philippe P, McIntyre JA; CHER Study Team. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med. 2008 Nov 20;359(21):2233-44. doi: 10.1056/NEJMoa0800971.
Diaz C, Hanson C, Cooper ER, Read JS, Watson J, Mendez HA, Pitt J, Rich K, Smeriglio V, Lew JF. Disease progression in a cohort of infants with vertically acquired HIV infection observed from birth: the Women and Infants Transmission Study (WITS). J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Jul 1;18(3):221-8.
Tovo PA, de Martino M, Gabiano C, Cappello N, D'Elia R, Loy A, Plebani A, Zuccotti GV, Dallacasa P, Ferraris G, et al. Prognostic factors and survival in children with perinatal HIV-1 infection. The Italian Register for HIV Infections in Children. Lancet. 1992 May 23;339(8804):1249-53.
Newell ML, Coovadia H, Cortina-Borja M, Rollins N, Gaillard P, Dabis F; Ghent International AIDS Society (IAS) Working Group on HIV Infection in Women and Children. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet. 2004 Oct 2-8;364(9441):1236-43.
Chilongozi D, Wang L, Brown L, Taha T, Valentine M, Emel L, Sinkala M, Kafulafula G, Noor RA, Read JS, Brown ER, Goldenberg RL, Hoffman I; HIVNET 024 Study Team. Morbidity and mortality among a cohort of human immunodeficiency virus type 1-infected and uninfected pregnant women and their infants from Malawi, Zambia, and Tanzania. Pediatr Infect Dis J. 2008 Sep;27(9):808-14. doi: 10.1097/INF.0b013e31817109a4.
Dunn D; HIV Paediatric Prognostic Markers Collaborative Study Group. Short-term risk of disease progression in HIV-1-infected children receiving no antiretroviral therapy or zidovudine monotherapy: a meta-analysis. Lancet. 2003 Nov 15;362(9396):1605-11.
13. World Health Organization (2006) Report of the WHO Technical Reference Group, Paediatric HIV/ ART Care Guideline Group Meeting.
14. World Health Organization (2006) Antiretroviral therapy of HIV infection in infants and children in resource-limited settings: towards universal access. Available: http://www.who.int/ hiv/pub/guidelines/pmtctguidelines3.pdf. Accessed 17 November 2009.
Sherman GG, Cooper PA, Coovadia AH, Puren AJ, Jones SA, Mokhachane M, Bolton KD. Polymerase chain reaction for diagnosis of human immunodeficiency virus infection in infancy in low resource settings. Pediatr Infect Dis J. 2005 Nov;24(11):993-7.
16. United Nations Children's Fund (2008) Children and AIDS. Third Stocktaking Report, 2008. Available at: http:// www.unicef.org/publications. Accessed 17 November, 2009.
17. Ministry of Health Malawi and National AIDS Commission (2008) Treatment of AIDS: Guidelines for the Use of Antiretroviral Therapy in Malawi, Third Edition.
18. Ministry of Health Malawi and National AIDS Commission (2009) Early Infant Diagnosis Report, 24 August.
19. Kabue MM, Braun M, Aetker L, Chirwa M, Mofolo I, et al. (2009) ART initiation and increased survival of infants traced from PMTCT to pediatric HIV care: highlighting the need for program coordination in Lilongwe, Malawi. 5th Conference on HIV Pathogenesis, Treatment and Prevention. Cape Town, South Africa. Abstract WEPDD103.
Peltier CA, Omes C, Ndimubanzi PC, Ndayisaba GF, Stulac S, Arendt V, Courteille O, Muganga N, Kayumba K, Van den Ende J. Validation of 2006 WHO prediction scores for true HIV infection in children less than 18 months with a positive serological HIV test. PLoS One. 2009;4(4):e5312. doi: 10.1371/journal.pone.0005312. Epub 2009 Apr 24.
Inwani I, Mbori-Ngacha D, Nduati R, Obimbo E, Wamalwa D, John-Stewart G, Farquhar C. Performance of clinical algorithms for HIV-1 diagnosis and antiretroviral initiation among HIV-1-exposed children aged less than 18 months in Kenya. J Acquir Immune Defic Syndr. 2009 Apr 15;50(5):492-8. doi: 10.1097/QAI.0b013e318198a8a4.
Kilewo C, Karlsson K, Massawe A, Lyamuya E, Swai A, Mhalu F, Biberfeld G; Mitra Study Team. Prevention of mother-to-child transmission of HIV-1 through breast-feeding by treating infants prophylactically with lamivudine in Dar es Salaam, Tanzania: the Mitra Study. J Acquir Immune Defic Syndr. 2008 Jul 1;48(3):315-23. doi: 10.1097/QAI.0b013e31816e395c.
Kumwenda NI, Hoover DR, Mofenson LM, Thigpen MC, Kafulafula G, Li Q, Mipando L, Nkanaunena K, Mebrahtu T, Bulterys M, Fowler MG, Taha TE. Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. N Engl J Med. 2008 Jul 10;359(2):119-29. doi: 10.1056/NEJMoa0801941. Epub 2008 Jun 4.
Six Week Extended-Dose Nevirapine (SWEN) Study Team, Bedri A, Gudetta B, Isehak A, Kumbi S, Lulseged S, Mengistu Y, Bhore AV, Bhosale R, Varadhrajan V, Gupte N, Sastry J, Suryavanshi N, Tripathy S, Mmiro F, Mubiru M, Onyango C, Taylor A, Musoke P, Nakabiito C, Abashawl A, Adamu R, Antelman G, Bollinger RC, Bright P, Chaudhary MA, Coberly J, Guay L, Fowler MG, Gupta A, Hassen E, Jackson JB, Moulton LH, Nayak U, Omer SB, Propper L, Ram M, Rexroad V, Ruff AJ, Shankar A, Zwerski S. Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials. Lancet. 2008 Jul 26;372(9635):300-13. doi: 10.1016/S0140-6736(08)61114-9.
25. Chasela C, Hudgens M , Jamieson D , Kayira D , Hosseinipour M, et al. (2009) Both maternal HAART and daily infant nevirapine (NVP) are effective in reducing HIV-1 transmission during breastfeeding in a randomized trial in Malawi: 28 week results of the Breastfeeding, Antiretroviral and Nutrition (BAN) Study. 5th Conference on HIV Pathogenesis, Treatment and Prevention. Cape Town, South Africa. Abstract WELBC103.
26. World Health Organization (2008) World Malaria Report. Available: http://apps.who.int/malaria/wmr2008/malaria2008.pdf. Accessed 19 November 2009.